Healthcare Sector
Biotechnology & Pharmaceuticals Industry 
|
|
|
Data by Company within Biotechnology & Pharmaceuticals Industry
|
| |
Marketcap |
Revenues (TTM) |
Net Income (TTM) |
Employees |
| Company |
(Millions) |
(Millions) |
(Millions) |
Number |
| Abcam Plc |
$ 5,511 |
- |
$ 0 |
- |
| Acumen Pharmaceuticals Inc |
$ 130 |
- |
$ -82 |
30 |
| Atlantic Coastal Acquisition Corp Ii |
$ 4 |
- |
$ -2 |
- |
| Aceragen Inc |
$ 3 |
- |
$ -41 |
- |
| Achilles Therapeutics Plc |
$ 40 |
- |
$ -71 |
- |
| Arcellx Inc |
$ 4,691 |
$ 156 |
$ -40 |
- |
| Acorda Therapeutics Inc |
- |
$ 100 |
$ -62 |
- |
| Adaptimmune Therapeutics Plc |
$ 967 |
$ 181 |
$ -45 |
- |
| Fennec Pharmaceuticals Inc. |
- |
- |
$ 0 |
- |
| Adma Biologics Inc |
$ 4,754 |
$ 329 |
$ 35 |
401 |
| Adaptive Biotechnologies Corporation |
$ 941 |
$ 177 |
$ -195 |
709 |
| Adverum Biotechnologies Inc |
$ 124 |
$ 2 |
$ -94 |
79 |
| Aerie Pharmaceuticals Inc |
$ 729 |
$ 214 |
$ -37 |
259 |
| Agenus Inc |
$ 69 |
$ 160 |
$ -231 |
- |
| Applied Genetic Technologies Corporation |
$ 26 |
$ 42 |
$ -70 |
- |
| Aim Immunotech Inc |
$ 11 |
$ 0 |
$ -28 |
- |
| Avalon Globocare Corp |
$ 4 |
$ 1 |
$ -7 |
- |
| Alector Inc |
$ 207 |
$ 62 |
$ -158 |
244 |
| Aligos Therapeutics Inc |
$ 217 |
$ 6 |
$ -77 |
- |
| Allogene Therapeutics Inc |
$ 448 |
$ 0 |
$ -287 |
300 |
| Allena Pharmaceuticals Inc. |
$ 8 |
- |
$ -43 |
- |
| Alvotech |
- |
- |
$ 0 |
- |
| Allovir Inc |
$ 58 |
- |
$ -100 |
- |
| Ambrx Biopharma Inc |
$ 1,743 |
$ 9 |
$ -134 |
- |
| Amarantus Bioscience Holdings, Inc. |
- |
- |
$ 0 |
- |
| Amarantus Bioscience Holdings, Inc. |
- |
- |
$ 0 |
- |
| Amgen Inc |
$ 147,901 |
$ 32,534 |
$ 4,230 |
25,200 |
| Albany Molecular Research Inc |
$ 928 |
$ 681 |
$ -60 |
- |
| Aeolus Pharmaceuticals, Inc. |
$ 0 |
$ 1 |
$ -4 |
- |
| Apogee Therapeutics Inc |
$ 2,770 |
- |
$ -136 |
- |
| Apeiron Capital Investment Corp |
$ 16 |
- |
$ 2 |
- |
| Aptose Biosciences Inc |
$ 3 |
- |
$ -36 |
- |
| Argenx se |
$ 34,828 |
$ 2,495 |
$ -295 |
- |
| Ariad Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
| Armo Biosciences, Inc. |
- |
- |
$ 0 |
- |
| Armata Pharmaceuticals Inc |
$ 80 |
$ 5 |
$ -41 |
10 |
| Arno Therapeutics, Inc |
- |
- |
$ 0 |
- |
| Artiva Biotherapeutics Inc |
$ 220 |
- |
$ 0 |
- |
| Asterias Biotherapeutics, Inc. |
$ 51 |
$ 3 |
$ -24 |
- |
| Athira Pharma Inc |
$ 23 |
- |
$ -115 |
- |
| Atara Biotherapeutics Inc |
$ 88 |
$ 174 |
$ -133 |
- |
| Atyr Pharma Inc |
$ 240 |
- |
$ -64 |
- |
| Kubota Pharmaceutical Holdings Co Ltd |
- |
- |
$ 0 |
- |
| Aura Biosciences Inc |
$ 430 |
- |
$ -83 |
- |
| Autolus Therapeutics Plc |
$ 772 |
$ 0 |
$ -239 |
145 |
| Anavex Life Sciences Corp |
$ 691 |
$ 3 |
$ -42 |
16 |
| Axcella Health Inc |
$ 1 |
- |
$ -48 |
- |
| Old Ayala Inc |
$ 8 |
$ 1 |
$ -38 |
- |
| Bioatla Inc |
$ 74 |
- |
$ -82 |
- |
| Biocardia Inc |
$ 6 |
$ 0 |
$ -8 |
54 |
| Brainstorm Cell Therapeutics inc |
$ 8 |
- |
$ -14 |
25 |
| Biocryst Pharmaceuticals Inc |
$ 1,626 |
$ 413 |
$ -124 |
197 |
| Black Diamond Therapeutics Inc |
$ 142 |
- |
$ -73 |
140 |
| Beam Therapeutics Inc |
$ 2,382 |
$ 350 |
$ -144 |
- |
| Beesfree, Inc. |
$ 0 |
- |
$ -1 |
- |
| Bg Medicine, Inc. |
- |
- |
$ 0 |
- |
| Premier Biomedical Inc |
$ 0 |
$ 0 |
$ 0 |
- |
| Biogen Inc |
$ 22,794 |
$ 9,608 |
$ 1,614 |
7,570 |
| Immucor Inc |
- |
- |
$ 0 |
- |
| Bluebird Bio Inc |
$ 76 |
$ 53 |
$ -16 |
- |
| Biontech Se |
$ 28,987 |
$ 4,277 |
$ 1,042 |
1,700 |
| Bionovo Inc |
- |
- |
$ 0 |
- |
| Bohai Pharmaceuticals Group, Inc. |
$ 6 |
$ 179 |
$ 23 |
1,000 |
| Zeo Scientifix Inc |
$ 0 |
$ 5 |
$ -5 |
- |
| Cabaletta Bio Inc |
$ 152 |
- |
$ -104 |
- |
| Candel Therapeutics Inc |
$ 248 |
$ 0 |
$ -52 |
- |
| Cadence Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
| Cannabis Global Inc. |
$ 0 |
$ 4 |
$ -4 |
- |
| Cellular Biomedicine Group Inc |
$ 384 |
$ 0 |
$ -55 |
- |
| China Botanic Pharmaceutical |
- |
- |
$ 0 |
- |
| China Biologic Products Holdings Inc |
- |
$ 504 |
$ 163 |
4,572 |
| C4 Therapeutics Inc |
$ 328 |
$ 34 |
$ -105 |
80 |
| Cellcyte Genetics Corp. |
$ 0 |
- |
$ 0 |
- |
| Codiak Biosciences Inc |
$ 1 |
$ 34 |
$ -17 |
- |
| Cidara Therapeutics Inc |
$ 142 |
$ 65 |
$ -122 |
40 |
| Creative Medical Technology Holdings Inc |
$ 3 |
$ 0 |
$ -5 |
11 |
| Cullinan Therapeutics Inc |
$ 730 |
- |
$ -145 |
2 |
| Compugen Ltd |
$ 138 |
$ 8 |
$ -34 |
- |
| Cg Oncology Inc |
$ 2,130 |
- |
$ 0 |
- |
| Cognition Therapeutics inc |
$ 20 |
- |
$ -34 |
- |
| Chromocell Therapeutics Corporation |
$ 4 |
- |
$ 0 |
- |
| Coherus Biosciences inc |
$ 190 |
$ 304 |
$ 0 |
766 |
| Chelsea Therapeutics International, Ltd. |
- |
- |
$ -18 |
- |
| China Kangtai Cactus Bio-tech, Inc. |
- |
- |
$ 0 |
- |
| Calidi Biotherapeutics Inc |
$ 10 |
- |
$ -37 |
- |
| Cellectis S a |
$ 85 |
$ 57 |
$ -125 |
- |
| Checkmate Pharmaceuticals Inc |
$ 227 |
- |
$ -63 |
- |
| Compass Therapeutics Inc |
$ 230 |
- |
$ -48 |
99 |
| Compass Biotechnologies Inc. |
- |
- |
$ 0 |
- |
| Coeptis Therapeutics Holdings Inc |
$ 7 |
- |
$ -12 |
- |
| Core Lithium Corp. |
$ 251 |
- |
$ -4 |
- |
| Caribou Biosciences Inc |
$ 183 |
$ 11 |
$ -148 |
- |
| Cardiff Oncology Inc |
$ 173 |
$ 3 |
$ -43 |
25 |
| Cardiol Therapeutics inc |
$ 92 |
- |
$ -22 |
- |
| Cargo Therapeutics Inc |
$ 782 |
- |
$ -87 |
- |
| Curis Inc |
$ 23 |
$ 10 |
$ -45 |
45 |
| Crispr Therapeutics Ag |
$ 4,073 |
$ 203 |
$ -240 |
- |
| Gene Biotherapeutics Inc |
$ 0 |
- |
$ -1 |
- |
| Clarus Therapeutics Holdings Inc. |
$ 2 |
$ 8 |
$ -23 |
- |
| Champions Oncology Inc |
$ 82 |
$ 52 |
$ -3 |
121 |
| Cel sci Corporation |
$ 36 |
- |
$ -29 |
13 |
| Cyclo Therapeutics Inc |
$ 17 |
$ 1 |
$ -20 |
- |
| Dbv Technologies S a |
$ 317 |
$ 13 |
$ -102 |
- |
| Diadexus, Inc. |
- |
- |
$ 0 |
- |
| Dimension Therapeutics, Inc. |
$ 149 |
$ 17 |
$ -56 |
- |
| Ginkgo Bioworks Holdings Inc |
$ 559 |
$ 239 |
$ -742 |
500 |
| Dendreon Corp |
- |
$ 299 |
$ -162 |
- |
| Denali Therapeutics Inc |
$ 4,045 |
$ 341 |
$ -366 |
445 |
| Noho, Inc. |
$ 0 |
$ 1 |
$ -6 |
- |
| Ds Healthcare Group, Inc. |
$ 0 |
$ 12 |
$ -6 |
105 |
| Precision Biosciences Inc |
$ 41 |
$ 75 |
$ 9 |
- |
| Dyadic International Inc |
$ 49 |
$ 3 |
$ -6 |
84 |
| Editas Medicine Inc |
$ 164 |
$ 62 |
$ -211 |
143 |
| Eiger Biopharmaceuticals Inc |
$ 3 |
$ 16 |
$ -75 |
- |
| Elevation Oncology inc |
$ 43 |
- |
$ -42 |
- |
| Eloxx Pharmaceuticals Inc |
$ 0 |
- |
$ -32 |
- |
| Elutia Inc |
$ 142 |
$ 24 |
$ -54 |
- |
| Engene Holdings Inc |
$ 331 |
- |
$ 0 |
- |
| Entera Bio Ltd |
$ 84 |
- |
$ 9 |
- |
| Enumeral Biomedical Holdings, Inc. |
$ 0 |
$ 2 |
$ -13 |
- |
| Enzon Pharmaceuticals inc |
$ 7 |
$ 2 |
$ 2 |
- |
| Enzymotec Ltd. |
- |
- |
$ 0 |
124 |
| Entia Biosciences, Inc. |
$ 0 |
$ 0 |
$ -1 |
- |
| Erytech Pharma S a |
$ 18 |
- |
$ -60 |
- |
| Tradeup Acquisition Corp |
$ 47 |
- |
$ -5 |
- |
| Eastgate Biotech Corp |
- |
$ 0 |
$ -3 |
- |
| Evaxion Biotech A |
$ 36 |
$ 0 |
$ -22 |
- |
| Exscientia Plc |
$ 241 |
- |
$ 0 |
- |
| Exelixis Inc |
$ 10,324 |
$ 2,082 |
$ 1,067 |
566 |
| Fate Therapeutics Inc |
$ 257 |
$ 13 |
$ -178 |
220 |
| 4d Molecular Therapeutics Inc |
$ 383 |
$ 0 |
$ -143 |
- |
| Fennec Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
| Forma Therapeutics Holdings Inc. |
- |
- |
$ -190 |
- |
| Finch Therapeutics Group Inc |
$ 19 |
$ 1 |
$ -13 |
- |
| Freeline Therapeutics Holdings Plc |
$ 384 |
- |
$ -140 |
- |
| Fresh Tracks Therapeutics Inc |
$ 4 |
$ 10 |
$ -6 |
- |
| Global Future City Holding Inc. |
$ 3 |
$ 3 |
$ -5 |
- |
| Fusion Pharmaceuticals Inc |
$ 1,805 |
$ 2 |
$ -104 |
- |
| Agentix Corp |
- |
- |
$ 0 |
2 |
| Genetic Technologies Ltd |
- |
$ 0 |
$ -6 |
- |
| Gentium S.p.a. |
- |
- |
$ 0 |
- |
| Synageva Biopharma Corp |
- |
- |
$ 0 |
- |
| Gilead Sciences Inc |
$ 116,446 |
$ 28,299 |
$ 114 |
18,000 |
| Monte Rosa Therapeutics Inc |
$ 698 |
- |
$ -119 |
- |
| Gamida Cell Ltd |
$ 6 |
- |
$ 79 |
- |
| Genocea Biosciences Inc |
$ 0 |
$ 21 |
$ -37 |
- |
| Genfit S a |
$ 191 |
$ 43 |
$ -32 |
194 |
| Aevi Genomic Medicine, Inc. |
$ 11 |
- |
$ -18 |
- |
| Genenta Science S p a |
$ 94 |
- |
$ -13 |
- |
| Green Planet Bioengineering Co Ltd |
$ 0 |
- |
$ 0 |
- |
| Greenlight Biosciences Holdings Pbc |
$ 45 |
$ 10 |
$ -157 |
- |
| Gritstone Bio Inc |
$ 5 |
$ 15 |
$ -201 |
- |
| Genethera Inc |
- |
- |
$ -1 |
- |
| Halozyme Therapeutics Inc |
$ 6,288 |
$ 947 |
$ 392 |
3,011 |
| Hillevax Inc |
$ 98 |
- |
$ -150 |
- |
| Hyperion Therapeutics Inc |
- |
- |
$ 0 |
- |
| Humacyte Inc |
$ 493 |
$ 0 |
$ -153 |
150 |
| Immunitybio inc |
$ 2,160 |
$ 7 |
$ -588 |
167 |
| Icosavax Inc |
$ 766 |
$ 1 |
$ -97 |
- |
| Ikena Oncology Inc |
$ 82 |
$ 9 |
$ -60 |
- |
| Inhibikase Therapeutics Inc |
$ 28 |
$ 0 |
$ -20 |
- |
| Intellect Neurosciences, Inc. |
$ 0 |
- |
$ -15 |
- |
| Immunocore Holdings Plc |
$ 1,625 |
- |
$ 0 |
285 |
| Epicure Charcoal, Inc. |
$ 0 |
- |
$ 0 |
- |
| Immunovant Inc |
$ 4,231 |
- |
$ -323 |
146 |
| In8bio Inc |
$ 15 |
- |
$ -32 |
- |
| Inhibrx Biosciences Inc |
$ 234 |
$ 2 |
$ 1,642 |
103 |
| Mink Therapeutics Inc |
$ 26 |
- |
$ -14 |
- |
| Inmune Bio Inc |
$ 106 |
$ 0 |
$ -41 |
22 |
| Intensity Therapeutics Inc |
$ 32 |
- |
$ -15 |
- |
| Iovance Biotherapeutics inc |
$ 2,602 |
$ 91 |
$ -410 |
200 |
| Innate Pharma Sa |
$ 142 |
$ 69 |
$ -8 |
- |
| Century Therapeutics inc |
$ 114 |
$ 3 |
$ -130 |
75 |
| Iteos Therapeutics Inc |
$ 358 |
$ 128 |
$ -121 |
157 |
| Invivyd Inc |
$ 69 |
- |
$ -225 |
- |
| Jounce Therapeutics inc |
$ 97 |
$ 148 |
$ 0 |
125 |
| Jasper Therapeutics Inc |
$ 337 |
- |
$ -64 |
24 |
| Juno Therapeutics, Inc. |
$ 9,815 |
$ 112 |
$ -437 |
- |
| Cadus Corp |
$ 42 |
- |
$ -3 |
- |
| Kite Pharma, Inc. |
$ 10,187 |
$ 32 |
$ -359 |
- |
| Kaleido Biosciences Inc |
$ 0 |
$ 1 |
$ -87 |
- |
| Kodiak Sciences Inc |
$ 436 |
- |
$ -192 |
- |
| Kiromic Biopharma Inc |
$ 0 |
- |
$ -25 |
20 |
| Krystal Biotech Inc |
$ 5,249 |
$ 242 |
$ 52 |
98 |
| Kymera Therapeutics Inc |
$ 3,229 |
$ 88 |
$ -167 |
- |
| Kyverna Therapeutics Inc |
$ 196 |
- |
$ 0 |
- |
| Ladrx Corporation |
$ 1 |
- |
$ -3 |
- |
| Lescarden Inc |
- |
- |
$ 0 |
- |
| Lineage Cell Therapeutics Inc |
$ 106 |
$ 9 |
$ -20 |
- |
| Lenz Therapeutics Inc |
$ 845 |
- |
$ -161 |
- |
| La Jolla Pharmaceutical Company |
$ 200 |
$ 46 |
$ 4 |
- |
| Luckwel Pharmaceuticals Inc. |
- |
- |
$ 0 |
- |
| Lexeo Therapeutics Inc |
$ 249 |
- |
$ -52 |
- |
| Mabvax Therapeutics Holdings, Inc. |
$ 2 |
- |
$ -20 |
- |
| Multicell Technologies, Inc. |
$ 1 |
$ 1 |
$ 0 |
- |
| Mesoblast Ltd |
$ 10,296 |
$ 6 |
$ -88 |
162 |
| Meiragtx Holdings Plc |
$ 441 |
$ 14 |
$ -88 |
106 |
| Metagenomi Inc |
$ 145 |
- |
$ 0 |
- |
| Manhattan Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
| Miromatrix Medical inc |
$ 93 |
$ 1 |
$ -32 |
- |
| Mj Pharmaceuticals Inc. |
- |
- |
$ 0 |
- |
| Momenta Pharmaceuticals inc |
$ 6,187 |
$ 30 |
$ -228 |
- |
| Molecular Partners Ag |
$ 181 |
$ 7 |
$ -62 |
- |
| Moderna Inc |
$ 17,101 |
$ 5,081 |
$ -2,224 |
5,600 |
| Mymetics Corporation |
$ 0 |
$ 1 |
$ -14 |
- |
| Myrexis, Inc. |
- |
- |
$ -12 |
- |
| Neurocrine Biosciences Inc |
$ 13,373 |
$ 2,243 |
$ 386 |
1,400 |
| Northsight Capital, Inc. |
- |
$ 0 |
$ -2 |
- |
| Nexus Biopharma Inc |
- |
- |
$ 0 |
- |
| Nightstar Therapeutics Plc |
$ 1,034 |
- |
$ -53 |
- |
| Nkgen Biotech Inc |
$ 13 |
- |
$ -119 |
- |
| Neumora Therapeutics Inc |
$ 1,679 |
- |
$ -132 |
- |
| Nanostring Technologies Inc |
$ 5 |
$ 162 |
$ -166 |
721 |
| Nbty Inc |
- |
- |
$ 0 |
- |
| Nutrastar International Inc. |
$ 0 |
$ 44 |
$ 23 |
- |
| Novavax inc |
$ 1,412 |
$ 885 |
$ -285 |
370 |
| N-viro International Corporation |
- |
- |
$ 0 |
- |
| Ocugen Inc |
$ 237 |
$ 9 |
$ -40 |
47 |
| Omega Therapeutics Inc |
$ 52 |
$ 8 |
$ -73 |
- |
| Spark Therapeutics Inc |
$ 4,264 |
$ 70 |
$ -33 |
- |
| Organovo Holdings Inc |
$ 7 |
$ 0 |
$ 1 |
- |
| Opthea Limited |
$ 2,127 |
$ 0 |
$ -220 |
- |
| Orchard Therapeutics Plc |
$ 3,814 |
$ 22 |
$ -73 |
- |
| Osiris Therapeutics, Inc. |
$ 656 |
$ 113 |
$ 5 |
- |
| Outlook Therapeutics Inc |
$ 41 |
- |
$ -94 |
24 |
| Oncovista Innovative Therapies, Inc |
$ 0 |
- |
$ -3 |
- |
| Oyster Point Pharma Inc |
$ 300 |
$ 20 |
$ -235 |
- |
| Palisade Bio Inc |
$ 4 |
- |
$ -14 |
- |
| Passage Bio Inc |
$ 47 |
- |
$ -69 |
- |
| Phoenix Biotech Acquisition Corp |
$ 94 |
- |
$ -5 |
- |
| Point Of Care Nano technology Inc |
$ 0 |
- |
$ 0 |
- |
| Vaxcyte Inc |
$ 11,178 |
- |
$ -508 |
206 |
| Quint Media Inc. |
- |
- |
$ 0 |
- |
| Biomx Inc |
$ 11 |
- |
$ 11 |
- |
| Peak Bio Inc |
$ 1 |
- |
$ -3 |
- |
| Pluri Inc |
$ 28 |
$ 1 |
$ -22 |
- |
| Protalix Biotherapeutics inc |
$ 146 |
$ 46 |
$ -10 |
55 |
| Pharmacyte Biotech Inc |
- |
- |
$ 24 |
- |
| Prime Medicine Inc |
$ 378 |
- |
$ -105 |
- |
| Prokidney Corp |
$ 259 |
- |
$ -137 |
- |
| Prevail Therapeutics Inc |
$ 774 |
- |
$ -24 |
- |
| Poseida Therapeutics Inc |
$ 936 |
$ 151 |
$ -61 |
330 |
| Polarityte Inc |
$ 2 |
$ 3 |
$ -8 |
- |
| Mosaic Immunoengineering Inc |
$ 0 |
- |
$ -1 |
- |
| Qiagen N v |
$ 10,645 |
$ 1,901 |
$ 341 |
5,700 |
| Quince Therapeutics Inc |
$ 88 |
- |
$ -11 |
- |
| Qrons Inc |
$ 2 |
- |
$ 0 |
- |
| Quint Media Inc. |
- |
- |
$ 0 |
- |
| Rich Pharmaceuticals, Inc. |
$ 1 |
- |
$ -2 |
- |
| Regenocell Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Renovacor Inc |
$ 56 |
- |
$ -4 |
- |
| Receptos, Inc. |
- |
- |
$ -178 |
- |
| Replicel Life Sciences Inc |
- |
- |
$ -1 |
- |
| Replimune Group Inc |
$ 995 |
- |
$ -213 |
90 |
| Restorgenex Corp |
- |
- |
$ -26 |
- |
| Regado Biosciences Inc |
- |
- |
$ 0 |
- |
| Repligen Corp |
$ 8,703 |
$ 634 |
$ -8 |
1,800 |
| Regenxbio Inc |
$ 449 |
$ 84 |
$ -239 |
344 |
| Relay Therapeutics Inc |
$ 686 |
$ 35 |
$ -345 |
- |
| Aytu Bioscience, Inc. |
- |
- |
$ 0 |
- |
| Ruthigen, Inc. |
- |
- |
$ 0 |
- |
| Rubius Therapeutics Inc |
$ 5 |
- |
$ -180 |
- |
| Revolution Medicines Inc |
$ 7,702 |
$ 30 |
$ -567 |
- |
| Redwoods Acquisition Corp |
$ 129 |
- |
$ -3 |
- |
| Radient Pharmaceuticals Corp |
- |
- |
$ 0 |
- |
| Recursion Pharmaceuticals Inc |
$ 2,087 |
$ 65 |
$ -378 |
400 |
| Sab Biotherapeutics Inc |
$ 35 |
$ 3 |
$ -46 |
- |
| Sana Biotechnology Inc |
$ 519 |
- |
$ -306 |
- |
| Scilex Holding Company |
$ 61 |
$ 51 |
$ -119 |
- |
| Scinai Immunotherapeutics Ltd |
$ 5,289 |
- |
$ 7 |
- |
| Seagen Inc |
$ 43,034 |
$ 2,300 |
$ -750 |
2,700 |
| Sangamo Therapeutics Inc |
$ 394 |
$ 52 |
$ -136 |
405 |
| Shengtai Pharmaceutical, Inc. |
$ 0 |
- |
$ 0 |
- |
| Solid Biosciences Inc |
$ 195 |
$ 15 |
$ -102 |
- |
| Silexion Therapeutics Corp |
$ 18 |
- |
$ 0 |
- |
| Senti Biosciences Inc |
$ 26 |
$ 4 |
$ -67 |
27 |
| Spk Acquisition Corp |
- |
- |
$ -1 |
- |
| Sqz Biotechnologies Company |
$ 1 |
- |
$ 0 |
- |
| Sorrento Therapeutics Inc |
$ 18 |
- |
$ 0 |
- |
| Scholar Rock Holding Corp |
$ 4,059 |
$ 47 |
$ -226 |
43 |
| Surrozen Inc |
$ 30 |
- |
$ -46 |
- |
| Spotlight Innovation Inc. |
$ 0 |
$ 0 |
$ -4 |
2 |
| Sutro Biopharma Inc |
$ 190 |
$ 161 |
$ -124 |
- |
| Surface Oncology Inc |
$ 65 |
$ 31 |
$ -93 |
- |
| Savient Pharmaceuticals Inc |
- |
$ 21 |
$ -110 |
- |
| Springworks Therapeutics Inc |
- |
- |
$ -348 |
62 |
| Protara Therapeutics Inc |
$ 138 |
- |
$ -42 |
35 |
| Tarsus Pharmaceuticals Inc |
$ 1,929 |
$ 130 |
$ -134 |
25 |
| Tobira Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Tc Biopharm holdings Plc |
$ 2 |
$ 4 |
$ -1 |
- |
| Tracon Pharmaceuticals Inc |
$ 0 |
$ 11 |
$ 5 |
- |
| Tcr2 Therapeutics Inc |
$ 62 |
- |
$ -163 |
- |
| Tscan Therapeutics Inc |
$ 356 |
$ 9 |
$ -111 |
- |
| Bio techne Corp |
$ 12,423 |
$ 1,155 |
$ 131 |
2,300 |
| Tectonic Therapeutic Inc |
$ 719 |
- |
$ 0 |
- |
| Telik Inc |
- |
- |
$ -5 |
- |
| Mabvax Therapeutics Holdings, Inc. |
- |
- |
$ 0 |
- |
| Tg Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Instil Bio Inc |
$ 138 |
$ 1 |
$ -130 |
92 |
| Tenaya Therapeutics Inc |
$ 263 |
- |
$ -117 |
- |
| Targeted Medical Pharma, Inc. |
- |
- |
$ 0 |
- |
| Targacept Inc |
- |
- |
$ 0 |
- |
| Tourmaline Bio Inc |
$ 587 |
- |
$ -49 |
53 |
| Turnstone Biologics Corp |
$ 11 |
- |
$ -19 |
- |
| Taysha Gene Therapies Inc |
$ 605 |
$ 10 |
$ -23 |
- |
| Trius Therapeutics Inc |
- |
$ 14 |
$ -69 |
- |
| Titan Pharmaceuticals Inc |
$ 3 |
$ 2 |
$ -5 |
13 |
| Tevogen Bio Holdings Inc |
$ 160 |
- |
$ 3 |
- |
| Twist Bioscience Corporation |
$ 2,787 |
$ 313 |
$ -209 |
750 |
| Taxus Pharmaceuticals Holdings, Inc. |
$ 2,201 |
- |
$ 0 |
- |
| Uluru Inc. |
$ 35 |
$ 1 |
$ -2 |
- |
| United Bancshares Inc |
- |
$ 4 |
$ -1 |
- |
| Valneva Se |
$ 550 |
$ 172 |
$ -114 |
550 |
| Vericel Corporation |
$ 2,843 |
$ 227 |
$ 4 |
280 |
| 10x Capital Venture Acquisition Corp Iii |
- |
- |
$ -1 |
- |
| Vectivbio Holding Ag |
$ 745 |
$ 27 |
$ -94 |
- |
| Vigil Neuroscience Inc |
$ 89 |
- |
$ -83 |
- |
| Vir Biotechnology Inc |
$ 1,069 |
$ 79 |
$ -533 |
146 |
| Vor Biopharma Inc |
$ 67 |
- |
$ -112 |
- |
| Viropharma Inc |
- |
$ 550 |
$ -4 |
- |
| Ventrus Biosciences Inc |
- |
- |
$ 0 |
- |
| Vaxart Inc |
$ 139 |
$ 17 |
$ -72 |
- |
| Voyager Therapeutics Inc |
$ 367 |
$ 164 |
$ 26 |
46 |
| Windtree Therapeutics Inc |
$ 0 |
$ 1 |
$ -9 |
19 |
| X4 Pharmaceuticals Inc |
$ 146 |
- |
$ 0 |
- |
| Acceleron Pharma inc |
$ 10,892 |
$ 113 |
$ -255 |
450 |
| Xstelos Holdings, Inc. |
- |
$ 28 |
$ 14 |
- |
| Xtant Medical Holdings Inc |
$ 52 |
$ 100 |
$ -2 |
- |
| Zivo Bioscience Inc |
$ 66 |
$ 0 |
$ -14 |
2 |
| Zura Bio Limited |
$ 196 |
- |
$ 5 |
- |
| Biotechnology & Pharmaceuticals Industry |
$ 666,430 |
$ 104,534 |
$ -13,381 |
94,174 |
| Earnings |
|
Earnings |
|
Earnings |
|
Earnings Outlook increase
Looking into earnings estimates within the Biotechnology & Pharmaceuticals Industry in the current quarter, 33.33 % of companies, who provide earning guidance within Biotechnology & Pharmaceuticals Industry have increased their earnings outlook for the current fiscal year. But this falls short, as more corporations cut their earnings estimates. |
Earnings Guidance unchanged
In the same quarter, none of those companies, who issued earnings outlook, has reiterated its earnings estimates within the Biotechnology & Pharmaceuticals Industry. |
Earnings Estimates
decrease
Pessimism dominates within Biotechnology & Pharmaceuticals Industry, as most of the businesses cut their earnings guidance, staggering 66.67 % have revised down earnings outlook. Overall earnings expectations for the Biotechnology & Pharmaceuticals Industry were cut by %, to the annual earnings expectation of %. |
|
Expected
Eps Growth |
|
|
Eps
Expectation Revision |
|
 |
% Industry
Expected EPS Growth |
|
Total Ranking # Within Sector # |
|
|
|
% Industry
Earnings Outlook Revision |
|
Total Ranking # Within Sector # |
|
|
|
Revenue |
|
Revenue |
|
Revenue |
Sales Forecast increase
In the current quarter 66.67 % of companies, who have issued revenue expectation within Biotechnology & Pharmaceuticals Industry, have expressed their optimism, by increasing revenue outlook for the current fiscal year. |
Sales Expectations unchanged
Among companies who provide sales guidance within Biotechnology & Pharmaceuticals Industry 33.33 %, have reiterated own sales estimates for the current fiscal year. |
Sales Outlook decrease
In Biotechnology & Pharmaceuticals Industry, there were no sales guidance decreases |
|
Expected
Revenue Growth |
|
|
Revenue
Expectation Revision |
|
|
|
% Industry
Expected Revenue Growth |
|
Total Ranking # Within Sector # |
|
|
|
% Industry
Revenue Outlook Revision |
|
Total Ranking # Within Sector # |
|
|
|
